EPISODE · Sep 19, 2024 · 57 MIN
37. Australia Has Access to Enhertu—England’s Stage 4 Breast Cancer Patients Deserve the Same.
from The Hurdle2Hope® Show · host Teisha Rose
How would you feel if access to life-extending treatment was denied?Living with stage 4 breast cancer is hard enough. I get it—I was diagnosed in February 2022. However, living in Australia, if my cancer were to become HER2-low, I have the comfort of knowing that the life-extending drug Enhertu is now available through our Pharmaceutical Benefits Scheme. Yet, this same drug remains out of reach for women with HER2-low breast cancer in England.It isn't fair. So, I reached out to the incredible Jeannie Ambrose, who is living with stage 4 breast cancer in England, to discuss the emotional impact of being denied access to this treatment. In this episode, we not only highlight the profound frustration but also support the campaign fighting for access to Enhertu in the UK. Let’s shine a light on this injustice and raise awareness of the need for equal access to life-extending treatments. If you LOVED the episode, make sure to share this on your Instagram stories and tag us @hurdle2hope and @jambeannieKey Episode Takeaways: Understanding the Diagnosis: Jeannie’s Journey with Stage 4 Breast CancerWhy the Fight for Access to Enhertu MattersThe Emotional Toll of Inequality in Treatment AccessEnhertu: What Is It and Who Benefits?The Personal Is Political: Why We Should CareHow You Can Help: Taking ActionShow Resources:Follow Jeannie Ambrose on InstagramVisit Breast Cancer Now to support the Enhertu campaign in the UK.Follow @thetittygritty for updates on the fight for access to Enhertu.About the Guest: Jeannie Ambrose lives in Cambridgeshire, England, and was diagnosed with stage 4 breast cancer de novo over five years ago. Now, as a HER2-low breast cancer patient, she is a patient advocate and has been involved with Breast Cancer Now to campaign for access to the life-extending drug Enhertu. Jeannie shares the personal impact of being denied access to this drug. For further details on why this decision was made and the efforts to gain access to the drug, please visit the Breast Cancer Now Enhertu Campaign. If you enjoyed this episode, don't forget to share it on your Instagram stories and tag me @hurdle2hope @jambeannie.Other than that, enjoy the episode – chat next week!Send Teisha a text message ❤️🧡💚 If you’re feeling overwhelmed by a health challenge, download the free guide here: https://teisharose.com/overwhelmed/ If you’re ready for more support, explore the Thriving Through Chronic Illness course and one-on-one coaching here: https://teisharose.com/thrivingWHERE TO GO NEXTIf you’re navigating a health challenge, you can find support and resources atTeishaRose.comIf you’re a professional or organisation looking to strengthen connection and resilience in your work, visitHurdle2Hope.comI’d love to connect with you,TeishaAlso, are you following @hurdle2hope on social media? I’d love to see you there.InstagramFacebookLinkedIn
Embed this episode
What this episode covers
How would you feel if access to life-extending treatment was denied? Living with stage 4 breast cancer is hard enough. I get it—I was diagnosed in February 2022. However, living in Australia, if my cancer were to become HER2-low, I have the comfort of knowing that the life-extending drug Enhertu is now available through our Pharmaceutical Benefits Scheme. Yet, this same drug remains out of reach for women with HER2-low breast cancer in England. It isn't fair. So, I reached out to the incredi...
NOW PLAYING
37. Australia Has Access to Enhertu—England’s Stage 4 Breast Cancer Patients Deserve the Same.
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.